Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weikang Probiotics is a leading Chinese biotechnology company focused on the research, development, and industrialization of probiotic strains and microbial derivatives. Headquartered in Suzhou, the company maintains an extensive library of functional microorganisms and operates state-of-the-art GMP-certified manufacturing facilities specializing in high-density fermentation and freeze-drying. Weikang provides a comprehensive range of products, including concentrated probiotic powders, starter cultures, and finished dosage forms for the food, healthcare, and pharmaceutical sectors. Their business model encompasses both proprietary product sales and CDMO services, supporting global partners in the development of microbiome-based health solutions. With a strong emphasis on clinical validation, Weikang has established itself as a key player in the global probiotics supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WeiKang Probiotics.